Stay updated on Nivolumab Alone or Combined With Ipilimumab in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Alone or Combined With Ipilimumab in Solid Tumors Clinical Trial page.

Latest updates to the Nivolumab Alone or Combined With Ipilimumab in Solid Tumors Clinical Trial page
- CheckyesterdayChange DetectedPadua, Italy, 35128 was deleted and Padova, Italy, 35128 was added in the Locations section.SummaryDifference0.0%

- Check8 days agoChange DetectedAdded a publication citation for the CheckMate-032 study (J Clin Oncol, 2018). Deleted the erratum note for that publication (J Clin Oncol, 2019).SummaryDifference0.0%

- Check16 days agoChange DetectedNapoli, Italy, 80131 was changed to Naples, Italy, 80131 in the Locations section.SummaryDifference0.0%

- Check23 days agoChange DetectedThe page's revision tag was updated to v3.5.0 and the previous v3.4.3 tag was removed.SummaryDifference0.0%

- Check30 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3. There are no visible changes to the study details or associated information.SummaryDifference0.0%

- Check37 days agoChange DetectedThe CheckMate-032 publication citation was added and then removed from the Publications section, resulting in no net change to the page content.SummaryDifference0.0%

Stay in the know with updates to Nivolumab Alone or Combined With Ipilimumab in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Alone or Combined With Ipilimumab in Solid Tumors Clinical Trial page.